There is evidence that SCFAs can have multiple beneficial effects in DM by stimulating glucagonlike peptide-1 (GLP-1) and insulin secretion, anti-inflammatory properties, anti-obesogenic effect, and improvement of insulin-sensitivity [18]. The gene discussed is GLP1R; the disease is diabetes mellitus.